180 related articles for article (PubMed ID: 32655683)
1. Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug-drug interactions.
Qin Z; Jia M; Yang J; Xing H; Yin Z; Yao Z; Zhang X; Yao X
Chin Med; 2020; 15():69. PubMed ID: 32655683
[TBL] [Abstract][Full Text] [Related]
2. Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions.
Olaleye OE; Niu W; Du FF; Wang FQ; Xu F; Pintusophon S; Lu JL; Yang JL; Li C
Acta Pharmacol Sin; 2019 Jun; 40(6):833-849. PubMed ID: 30327544
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, tissue distribution and excretion of saponins after intravenous administration of ShenMai Injection in rats.
Li Y; Wang H; Wang R; Lu X; Wang Y; Duan M; Li H; Fan X; Wang S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Oct; 1128():121777. PubMed ID: 31487566
[TBL] [Abstract][Full Text] [Related]
4. UHPLC coupled with mass spectrometry and chemometric analysis of Kang-Ai injection based on the chemical characterization, simultaneous quantification, and relative quantification of 47 herbal alkaloids and saponins.
Jia M; Zhang B; Qi Y; Yang J; Yao Z; Qin Z; Zhang X; Yao X
J Sep Sci; 2020 Jul; 43(13):2539-2549. PubMed ID: 32250549
[TBL] [Abstract][Full Text] [Related]
5.
Jang SN; Park SY; Lee H; Jeong H; Jeon JH; Song IS; Kwon MJ; Liu KH
Xenobiotica; 2021 Oct; 51(10):1087-1094. PubMed ID: 34338601
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3.
Jiang R; Dong J; Li X; Du F; Jia W; Xu F; Wang F; Yang J; Niu W; Li C
Br J Pharmacol; 2015 Feb; 172(4):1059-73. PubMed ID: 25297453
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of twenty-eight components of Shenfu Injection in rat plasma by UHPLC-QQQ MS and its application to a pharmacokinetic study.
Shen BQ; Qu C; Mi L; Wang HY; Yang H
J Pharm Biomed Anal; 2021 Sep; 203():114211. PubMed ID: 34171738
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the inhibition risk of paris saponins, bioactive compounds from Paris polyphylla, on CYP and UGT enzymes via cocktail inhibition assays.
Luo H; Xu Y; Sun D; Cheng Y; Sun Z; Gao J; Zhang Y; Wang X
Regul Toxicol Pharmacol; 2020 Jun; 113():104637. PubMed ID: 32145316
[TBL] [Abstract][Full Text] [Related]
9. Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).
Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Ge GB; Liu Y; Zhang YY; Yang L; Sun HZ
Toxicol Appl Pharmacol; 2013 Mar; 267(2):149-54. PubMed ID: 23306165
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms.
Lee H; Heo JK; Lee GH; Park SY; Jang SN; Kim HJ; Kwon MJ; Song IS; Liu KH
Drug Metab Dispos; 2019 Dec; 47(12):1372-1379. PubMed ID: 31578207
[TBL] [Abstract][Full Text] [Related]
11. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity.
Henderson GL; Harkey MR; Gershwin ME; Hackman RM; Stern JS; Stresser DM
Life Sci; 1999; 65(15):PL209-14. PubMed ID: 10574228
[TBL] [Abstract][Full Text] [Related]
12. Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions.
Pintusophon S; Niu W; Duan XN; Olaleye OE; Huang YH; Wang FQ; Li YF; Yang JL; Li C
Acta Pharmacol Sin; 2019 Oct; 40(10):1351-1363. PubMed ID: 31358899
[TBL] [Abstract][Full Text] [Related]
13. Herb-Drug Interaction of Red Ginseng Extract and Ginsenoside Rc with Valsartan in Rats.
Jeon JH; Lee S; Lee W; Jin S; Kwon M; Shin CH; Choi MK; Song IS
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023909
[TBL] [Abstract][Full Text] [Related]
14. High-level sustainable production of the characteristic protopanaxatriol-type saponins from Panax species in engineered Saccharomyces cerevisiae.
Li X; Wang Y; Fan Z; Wang Y; Wang P; Yan X; Zhou Z
Metab Eng; 2021 Jul; 66():87-97. PubMed ID: 33865981
[TBL] [Abstract][Full Text] [Related]
15. Ginsenosides in
Hou M; Wang R; Zhao S; Wang Z
Acta Pharm Sin B; 2021 Jul; 11(7):1813-1834. PubMed ID: 34386322
[TBL] [Abstract][Full Text] [Related]
16. Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impact on Drug-Drug Interaction Produced by Standardized CYP2C8 Inhibitors, Clopidogrel and Gemfibrozil.
Iga K; Kiriyama A
Clin Pharmacokinet; 2024 Jan; 63(1):43-56. PubMed ID: 37921907
[TBL] [Abstract][Full Text] [Related]
17. In vitro stereoselective inhibition of ginsenosides toward UDP-glucuronosyltransferase (UGT) isoforms.
Kim D; Zheng YF; Min JS; Park JB; Bae SH; Yoon KD; Chin YW; Oh E; Bae SK
Toxicol Lett; 2016 Sep; 259():1-10. PubMed ID: 27462006
[TBL] [Abstract][Full Text] [Related]
18. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
Kim SB; Kim KS; Kim DD; Yoon IS
Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of human liver cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes by rose bengal: system-dependent effects on inhibitory potential.
Kazmi F; Haupt LJ; Horkman JR; Smith BD; Buckley DB; Wachter EA; Singer JM
Xenobiotica; 2014 Jul; 44(7):606-14. PubMed ID: 24405273
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantification of twenty-one ginsenosides and their three aglycones in rat plasma by a developed UFLC-MS/MS assay: Application to a pharmacokinetic study of red ginseng.
Zhou QL; Zhu DN; Yang YF; Xu W; Yang XW
J Pharm Biomed Anal; 2017 Apr; 137():1-12. PubMed ID: 28086165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
